Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
OtherInflammation, Immunopharmacology, and Asthma

The CO-releasing molecule CORM-2 protects human osteoarthritic chondrocytes and cartilage from the catabolic actions of interleukin-1β

Javier Megias, Maria Isabel Guillen, Antonio Bru, Francisco Gomar and Maria Jose Alcaraz
Journal of Pharmacology and Experimental Therapeutics January 14, 2008, DOI: https://doi.org/10.1124/jpet.107.134650
Javier Megias
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Isabel Guillen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antonio Bru
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francisco Gomar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Jose Alcaraz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

DOI 
https://doi.org/10.1124/jpet.107.134650
PubMed 
18195133

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103

Article Versions

  • You are currently viewing an Earlier version of this article (January 14, 2008 - 11:56).
  • View the most recent version of this article

Author Information

Statistics from Altmetric.com

Article usage

Article usage: January 2008 to June 2022

AbstractFullPdf
Jan 200825079
Feb 200819065
Mar 200849961
Apr 2008332326
May 200839920
Jun 200836920
Jul 2008341214
Aug 200853622
Sep 200860920
Oct 2008611119
Nov 20084539
Dec 200817010
Jan 200939156
Feb 20091577
Mar 200932316
Apr 2009212118
May 2009131015
Jun 20099135
Jul 2009201215
Aug 2009575
Sep 2009221223
Oct 200936421
Nov 200925316
Dec 20093015
Jan 2010521816
Feb 201035722
Mar 2010111211
Apr 201011613
May 201041514
Jun 2010611122
Jul 2010211619
Aug 201050913
Sep 2010151021
Oct 201026920
Nov 2010141014
Dec 2010171318
Jan 2011141015
Feb 201114716
Mar 2011221016
Apr 2011131616
May 2011181522
Jun 201120615
Jul 2011131025
Aug 2011281017
Sep 2011311518
Oct 2011531212
Nov 2011311017
Dec 2011261715
Jan 201224717
Feb 2012242123
Mar 201241722
Apr 2012431019
May 2012371519
Jun 201224107
Jul 2012451113
Aug 201234312
Sep 201222913
Oct 201248612
Nov 201248813
Dec 2012131023
Jan 2013231113
Feb 201327109
Mar 2013221212
Apr 2013311313
May 201335714
Jun 2013281611
Jul 20131746
Aug 20131573
Sep 20132298
Oct 201316107
Nov 20131347
Dec 20132231
Jan 20141825
Feb 20142111
Mar 20143639
Apr 20142544
May 20141734
Jun 201436127
Jul 20142462
Aug 20142271
Sep 20141734
Oct 20141844
Nov 20141153
Dec 20142514
Jan 20151332
Feb 20151312
Mar 20152115
Apr 20151864
May 20151744
Jun 20151145
Jul 201510116
Aug 20151687
Sep 20152013
Oct 20152273
Nov 20151944
Dec 201515137
Jan 20161384
Feb 20161472
Mar 201616411
Apr 201615411
May 20161147
Jun 201611178
Jul 201610179
Aug 201615178
Sep 201610129
Oct 201621310
Nov 20160158
Dec 2016161
Jan 201772310
Feb 20171131
Mar 201702410
Apr 20170144
May 2017055
Jun 2017094
Jul 2017074
Aug 2017084
Sep 20171106
Oct 2017056
Nov 2017085
Dec 20170117
Jan 20180103
Feb 2018083
Mar 20182194
Apr 20180143
May 201801312
Jun 201811816
Jul 2018172
Aug 20180132
Sep 2018060
Oct 20180355
Nov 201805013
Dec 20183085
Jan 20192800
Feb 20191900
Mar 20191312
Apr 20198113
May 2019711
Jun 2019502
Jul 2019402
Aug 20191800
Sep 2019602
Oct 2019600
Nov 20192000
Dec 20191410
Jan 2020512
Feb 20201320
Mar 2020242
Apr 2020100
May 2020301
Jun 2020213
Jul 2020504
Aug 2020116
Sep 2020602
Oct 2020903
Nov 2020610
Dec 2020601
Jan 20211042
Feb 2021623
Mar 20211211
Apr 2021612
May 2021621
Jun 2021421
Jul 2021822
Aug 20211610
Sep 20211011
Oct 2021813
Nov 2021711
Dec 20211401
Jan 20221427
Feb 2022711
Mar 2022610
Apr 20221614
May 2022520
Jun 20221213

Next
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 381 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 381, Issue 3
1 Jun 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The CO-releasing molecule CORM-2 protects human osteoarthritic chondrocytes and cartilage from the catabolic actions of interleukin-1β
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherInflammation, Immunopharmacology, and Asthma

The CO-releasing molecule CORM-2 protects human osteoarthritic chondrocytes and cartilage from the catabolic actions of interleukin-1β

Javier Megias, Maria Isabel Guillen, Antonio Bru, Francisco Gomar and Maria Jose Alcaraz
Journal of Pharmacology and Experimental Therapeutics January 14, 2008, DOI: https://doi.org/10.1124/jpet.107.134650

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
OtherInflammation, Immunopharmacology, and Asthma

The CO-releasing molecule CORM-2 protects human osteoarthritic chondrocytes and cartilage from the catabolic actions of interleukin-1β

Javier Megias, Maria Isabel Guillen, Antonio Bru, Francisco Gomar and Maria Jose Alcaraz
Journal of Pharmacology and Experimental Therapeutics January 14, 2008, DOI: https://doi.org/10.1124/jpet.107.134650
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Pegylated UCN1 Improves Autoimmune disease
  • PK/PD of PDE Inhibitors in Autoimmune Hepatitis
  • Immunopharmacologic Assessment of KPL-404, a CD40 Antagonist
Show more Inflammation, Immunopharmacology, and Asthma

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics